Eptus (Inspra)25 Mg – 30 tablet

USD $47.54

Each Eptus contains 25 mg Eplerenone 30 tablets. It is used in the management of chronic heart failure and high blood pressure,

ATC Classification: C03DA04
Active Ingrediant: Eplerenone
Generic Name: Eptus
Manufacturer: Glenmark
Strength: 25 Mg
Dosage Type: Tablet
Packaging Type: Foil in Pharmacy Box
Contains: 10 Tab

Examples of Packages sent

Eplerenone Information

What is this drug used for?

– It is used to treat high blood pressure.
– It is used to help heart function after a heart attack.
– It may be given to you for other reasons. Talk with the doctor.

Possible side effects

Eplerenone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

– Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
– Signs of high potassium levels like a heartbeat that does not feel normal; feeling confused; feeling weak, lightheaded, or dizzy; feeling like passing out; numbness or tingling; or shortness of breath.
– Diarrhea.
– Throwing up.
– Chest pain or pressure or a fast heartbeat.
– Swelling in the arms or legs.
– Not able to pass urine or change in how much urine is passed.


Medication Safety Issues

Geriatric Patients: High-Risk Medication:

Beers Criteria: Diuretics (eplerenone) are identified in the Beers Criteria as potentially inappropriate medications to be used with caution in patients 65 years and older due to the potential to cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatremia; monitor sodium concentration closely when initiating or adjusting the dose in older adults (Beers Criteria [AGS 2019]).


Storage and Stability

Store at 25?C (77?F); excursions permitted to 15?C to 30?C (59?F to 86?F).


Adverse Reactions

>10%: Endocrine & metabolic: Hyperkalemia ([cardiac failure, post-myocardial infarction: >5.5 mEq/L: 16%; ?6 mEq/L: 6%], [hypertension, >5.5 mEq/L: at dose of 400 mg: 9%; dose ?200 mg: ?1%]), hypertriglyceridemia (1% to 15%; dose-related)

1% to 10%:

Central nervous system: Dizziness (3%), fatigue (2%)

Endocrine & metabolic: Hyponatremia (2%; dose-related), albuminuria (1%), gynecomastia (?1%), hypercholesterolemia (?1%)

Gastrointestinal: Diarrhea (2%), abdominal pain (1%)

Genitourinary: Abnormal vaginal hemorrhage (?2%), mastalgia (males: ?1%)

Renal: Increased serum creatinine (cardiac failure, post-myocardial infarction: 6%)

Respiratory: Cough (2%), flu-like symptoms (2%)

<1%, postmarketing, and/or case reports: Angioedema, increased blood urea nitrogen, increased liver enzymes, increased uric acid, skin rash

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “Eptus (Inspra)25 Mg – 30 tablet”

Your email address will not be published. Required fields are marked *